CHU de Liege /ID# 277971

Liège 4000

1 studies enrolling now · 1 studies all time

What they study most

Non-Squamous Non-Small Cell Lung Cancer

Studies at this site

• A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer — Recruiting now